{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:31:41Z","timestamp":1791232301881,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.tips.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T19:16:12Z","timestamp":1415646972000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?"],"prefix":"10.1016","volume":"36","author":[{"given":"Douglas B.","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2014.10.005_bib0005","series-title":"The Structure of Scientific Revolutions","author":"Kuhn","year":"1996"},{"key":"10.1016\/j.tips.2014.10.005_bib0010","series-title":"What is This Thing Called Science? An Assessment of the Nature and Status of Science and its Methods","author":"Chalmers","year":"1999"},{"key":"10.1016\/j.tips.2014.10.005_bib0015","series-title":"Opening Pandora's Box: A Sociological Analysis of Scientists\u2019 Discourse","author":"Gilbert","year":"1984"},{"key":"10.1016\/j.tips.2014.10.005_bib0020","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbagen.2013.09.037","article-title":"Aquaporins and membrane diffusion of CO2 in living organisms","volume":"1840","author":"Kaldenhoff","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2014.10.005_bib0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.drudis.2011.05.010","article-title":"Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only","volume":"16","author":"Kell","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.005_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd2438","article-title":"Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?","volume":"7","author":"Dobson","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.005_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): Introduction","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.tips.2014.10.005_bib0040","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/bph.12450","article-title":"The Concise Guide to PHARMACOLOGY 2013\/14: transporters","volume":"170","author":"Alexander","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2014.10.005_bib0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nbt1492","article-title":"A consensus yeast metabolic network obtained from a community approach to systems biology","volume":"26","author":"Herrg\u00e5rd","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2014.10.005_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nbt.2488","article-title":"A community-driven global reconstruction of human metabolism","volume":"31","author":"Thiele","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2014.10.005_bib0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11306-013-0564-3","article-title":"An analysis of a \u2018community-driven\u2019 reconstruction of the human metabolic network","volume":"9","author":"Swainston","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.tips.2014.10.005_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drudis.2008.10.011","article-title":"\u2018Metabolite-likeness\u2019 as a criterion in the design and selection of pharmaceutical drug libraries","volume":"14","author":"Dobson","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.005_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/156802609787521616","article-title":"Implications of the dominant role of cellular transporters in drug uptake","volume":"9","author":"Dobson","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.005_bib0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","article-title":"The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so","volume":"18","author":"Kell","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.005_bib0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7007-9-70","article-title":"Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast","volume":"9","author":"Lanthaler","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0080","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1111\/febs.12268","article-title":"Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening, and knowledge of transporters: where drug discovery went wrong and how to fix it","volume":"280","author":"Kell","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.tips.2014.10.005_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2013.07.014","article-title":"Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery","volume":"19","author":"Kell","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.005_bib0090","article-title":"A \u2018rule of 0.5\u2019 for the metabolite-likeness of approved pharmaceutical drugs","author":"O\u2019Hagan","year":"2014","journal-title":"Metabolomics"},{"key":"10.1016\/j.tips.2014.10.005_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00231","article-title":"How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion","volume":"5","author":"Kell","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2014.10.005_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bies.10385","article-title":"Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era","volume":"26","author":"Kell","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.tips.2014.10.005_bib0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.shpsa.2011.12.034","article-title":"Epistemic and methodological iteration in scientific research","volume":"43","author":"Elliott","year":"2012","journal-title":"Stud. Hist. Philos. Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0110","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nchembio.1590","article-title":"The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity","volume":"10","author":"Winter","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nbt.1857","article-title":"Global gene disruption in human cells to assign genes to phenotypes by deep sequencing","volume":"29","author":"Carette","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2014.10.005_bib0120","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nmeth.2609","article-title":"A reversible gene trap collection empowers haploid genetics in human cells","volume":"10","author":"B\u00fcrckst\u00fcmmer","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2014.10.005_bib0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/17460441.2013.748744","article-title":"Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes","volume":"8","author":"Pfefferkorn","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.005_bib0130","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1021\/ac060788p","article-title":"Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry","volume":"78","author":"Khatib-Shahidi","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tips.2014.10.005_bib0135","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jprot.2011.03.032","article-title":"Mass spectrometry imaging for drugs and metabolites","volume":"74","author":"Greer","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/j.tips.2014.10.005_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00216-011-4990-7","article-title":"Mass spectrometry imaging with high resolution in mass and space (HR2 MSI) for reliable investigation of drug compound distributions on the cellular level","volume":"401","author":"R\u00f6mpp","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.tips.2014.10.005_bib0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.005_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2014.10.005_bib0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/MMBR.60.4.641-696.1996","article-title":"Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analysis","volume":"60","author":"Davey","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.tips.2014.10.005_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1000664013047","article-title":"Viability and activity in readily culturable bacteria: a review and discussion of the practical issues","volume":"73","author":"Kell","year":"1998","journal-title":"Antonie van Leeuwenhoek"},{"key":"10.1016\/j.tips.2014.10.005_bib0165","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tips.2014.10.005_bib0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2010.11.007","article-title":"Emerging role for drug transporters at the blood\u2013testis barrier","volume":"32","author":"Mruk","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4614-4711-5_4","article-title":"The inner blood\u2013retinal barrier: molecular structure and transport biology","volume":"763","author":"Hosoya","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/clpt.2013.34","article-title":"Why clinical modulation of efflux transport at the human blood\u2013brain barrier is unlikely: the ITC evidence-based position","volume":"94","author":"Kalvass","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2014.10.005_bib0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.drudis.2011.08.006","article-title":"Pharmacogenetics: past, present and future","volume":"16","author":"Pirmohamed","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.005_bib0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tips.2014.10.005_bib0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jss.2009.03.052","article-title":"Diurnal expression and function of peptide transporter 1 (PEPT1)","volume":"156","author":"Qandeel","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.tips.2014.10.005_bib0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-62703-017-5_14","article-title":"Simulation studies of the mechanism of membrane transporters","volume":"924","author":"Enkavi","year":"2013","journal-title":"Method Mol. Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0210","doi-asserted-by":"crossref","first-page":"e63635","DOI":"10.1371\/journal.pone.0063635","article-title":"Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations","volume":"8","author":"Kolds\u00f8","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2014.10.005_bib0215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jmb.2013.10.024","article-title":"Flexible gates generate occluded intermediates in the transport cycle of LacY","volume":"426","author":"Stelzl","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0220","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF\u2013FDA TransPortal: a public drug transporter database","volume":"92","author":"Morrissey","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2014.10.005_bib0225","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2014.10.005_bib0230","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365520902745039","article-title":"Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions","volume":"44","author":"Andersson","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.tips.2014.10.005_bib0235","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00534-011-0440-3","article-title":"Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy","volume":"19","author":"Murata","year":"2012","journal-title":"J. Hepatobiliary Pancreat Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.005_bib0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.2013.45","article-title":"ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans","volume":"94","author":"Zamek-Gliszczynski","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2014.10.005_bib0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1124\/dmd.113.055806","article-title":"Uptake carriers and oncology drug safety","volume":"42","author":"Sprowl","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2014.10.005_bib0255","series-title":"Chemoinformatics for Drug Discovery","author":"Bajorath","year":"2014"},{"key":"10.1016\/j.tips.2014.10.005_bib0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"Broadhurst","year":"2006","journal-title":"Metabolomics"},{"key":"10.1016\/j.tips.2014.10.005_bib0265","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejps.2005.11.005","article-title":"Development and evaluation of an in vitro method for prediction of human drug absorption. II. Demonstration of the method suitability","volume":"27","author":"Corti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0270","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.tips.2014.10.005_bib0275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/157340910790980133","article-title":"Bioavailability through PepT1: the role of computer modelling in intelligent drug design","volume":"6","author":"Foley","year":"2010","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.tips.2014.10.005_bib0280","series-title":"The Structure of Biological Membranes","first-page":"273","article-title":"How to understand lipid\u2013protein interactions in biological membranes","author":"Lee","year":"2011"},{"key":"10.1016\/j.tips.2014.10.005_bib0285","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature13419","article-title":"Membrane proteins bind lipids selectively to modulate their structure and function","volume":"510","author":"Laganowsky","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2014.10.005_bib0290","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/cb500086e","article-title":"Phytochemicals perturb membranes and promiscuously alter protein function","volume":"9","author":"Ing\u00f3lfsson","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2014.10.005_bib0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrn2372","article-title":"General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal","volume":"9","author":"Franks","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2014.10.005_bib0300","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/310599a0","article-title":"Do general anaesthetics act by competitive binding to specific receptors?","volume":"310","author":"Franks","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.tips.2014.10.005_bib0305","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.tips.2014.10.005_bib0310","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2174\/156802612804910331","article-title":"Drug discovery applications for KNIME: an open source data mining platform","volume":"12","author":"Mazanetz","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.005_bib0315","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry","volume":"57","author":"Maggiora","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.005_bib0320","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/minf.201400024","article-title":"The calculation of molecular structural similarity: principles and practice","volume":"33","author":"Willett","year":"2014","journal-title":"Mol. Inf."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614714001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614714001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T12:57:56Z","timestamp":1598446676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614714001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0165614714001709"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2014.10.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725289169.793502698","asserted-by":"object"}]},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}